Roche, Quest Pen Broad Diagnostics Development Deal | GenomeWeb

NEW YORK, Oct. 18 – Roche Diagnostics and Quest Diagnostics have penned a deal to jointly develop gene-based tests to predict a person’s likelihood of developing particular diseases and to evaluate the best course of treatment.

The companies said they would work together to commercialize gene-based markers to determine a person’s risk for stroke or asthma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."